https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-09-04 / Cancer Immunol Immunother 2023 Nov;72(11):3727-3738
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-09-04 / Cancer Immunol Immunother 2023 Nov;72(11):3727-37382023-09-04 00:00:002023-09-04 00:00:00Combination therapy with dendritic cell loaded-exosomes supplemented with PD-1 inhibition at different time points have superior antitumor effect in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-08-12 / Vaccines (Basel) 2023 Aug;11(8)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-08-12 / Vaccines (Basel) 2023 Aug;11(8)2023-08-12 00:00:002023-08-12 00:00:00A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-04-10 / Genes (Basel) 2023 Apr;14(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-04-10 / Genes (Basel) 2023 Apr;14(4)2023-04-10 00:00:002023-04-10 00:00:00Transcriptome Analysis of Natural Killer Cells in Response to Newcastle Disease Virus Infected Hepatocellular Carcinoma Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-09-08 / Cancers (Basel) 2022 Sep;14(18)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-09-08 / Cancers (Basel) 2022 Sep;14(18)2022-09-08 00:00:002022-09-08 00:00:00Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-06-03 / Cancer Immunol Res 2022 Jun;10(6):728-744
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-06-03 / Cancer Immunol Res 2022 Jun;10(6):728-7442022-06-03 00:00:002022-06-03 00:00:00Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-1441
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-14412022-04-28 00:00:002022-04-28 00:00:00Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-01-07 / J Healthc Eng 2022;2022:2518847
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-01-07 / J Healthc Eng 2022;2022:25188472022-01-07 00:00:002022-01-07 00:00:00GP96 and SMP30 Protein Priming of Dendritic Cell Vaccination Induces a More Potent CTL Response against Hepatoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-14 / Acta Radiol 2023 Jan;64(1):32-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-14 / Acta Radiol 2023 Jan;64(1):32-412021-12-14 00:00:002023-01-31 12:51:13Evaluation of response in patients with hepatocellular carcinoma treated with intratumoral dendritic cell vaccination using intravoxel incoherent motion (IVIM) MRI and histogram analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-296
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-19 / J Clin Transl Hepatol 2022 Apr;10(2):284-2962021-11-19 00:00:002021-11-19 00:00:00Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-1996
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-01-28 / J Gastroenterol Hepatol 2021 Jul;36(7):1988-19962021-01-28 00:00:002021-01-28 00:00:00Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma
